HEADER VIRAL PROTEIN 16-APR-21 7ENE TITLE CRYSTAL STRUCTURE OF MERS-COV 3CLPRO IN COMPLEX WITH THE NON-COVALENT TITLE 2 INHIBITOR WU-04 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 3248-3553; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 3 ORGANISM_TAXID: 1335626; SOURCE 4 GENE: ORF1AB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NON-COVALENT, INHIBITOR, 3CLPRO, CORONAVIRUS, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.HOU,C.PENG,Q.HU REVDAT 4 29-NOV-23 7ENE 1 REMARK REVDAT 3 15-MAR-23 7ENE 1 JRNL REVDAT 2 08-FEB-23 7ENE 1 JRNL REVDAT 1 20-JUL-22 7ENE 0 JRNL AUTH N.HOU,L.SHUAI,L.ZHANG,X.XIE,K.TANG,Y.ZHU,Y.YU,W.ZHANG,Q.TAN, JRNL AUTH 2 G.ZHONG,Z.WEN,C.WANG,X.HE,H.HUO,H.GAO,Y.XU,J.XUE,C.PENG, JRNL AUTH 3 J.ZOU,C.SCHINDEWOLF,V.MENACHERY,W.SU,Y.YUAN,Z.SHEN,R.ZHANG, JRNL AUTH 4 S.YUAN,H.YU,P.Y.SHI,Z.BU,J.HUANG,Q.HU JRNL TITL DEVELOPMENT OF HIGHLY POTENT NONCOVALENT INHIBITORS OF JRNL TITL 2 SARS-COV-2 3CLPRO. JRNL REF ACS CENT.SCI. V. 9 217 2023 JRNL REFN ESSN 2374-7951 JRNL PMID 36844503 JRNL DOI 10.1021/ACSCENTSCI.2C01359 REMARK 2 REMARK 2 RESOLUTION. 2.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 25959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.550 REMARK 3 FREE R VALUE TEST SET COUNT : 1182 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.1800 - 5.9500 0.96 3092 144 0.1773 0.2034 REMARK 3 2 5.9500 - 4.7300 0.99 3115 150 0.2004 0.2168 REMARK 3 3 4.7200 - 4.1300 0.98 3105 150 0.2032 0.2435 REMARK 3 4 4.1300 - 3.7500 0.98 3076 144 0.2380 0.3066 REMARK 3 5 3.7500 - 3.4800 0.99 3087 151 0.2583 0.2824 REMARK 3 6 3.4800 - 3.2800 0.99 3116 142 0.2821 0.3312 REMARK 3 7 3.2800 - 3.1200 0.99 3113 154 0.3024 0.3754 REMARK 3 8 3.1200 - 2.9800 0.99 3073 147 0.3034 0.3614 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.629 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 9612 REMARK 3 ANGLE : 1.016 13092 REMARK 3 CHIRALITY : 0.058 1484 REMARK 3 PLANARITY : 0.006 1664 REMARK 3 DIHEDRAL : 16.994 3320 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 25.6357 -25.9784 69.0569 REMARK 3 T TENSOR REMARK 3 T11: 0.0948 T22: 0.1392 REMARK 3 T33: 0.1482 T12: -0.0657 REMARK 3 T13: 0.0347 T23: 0.0054 REMARK 3 L TENSOR REMARK 3 L11: 0.2674 L22: 0.3162 REMARK 3 L33: 1.3157 L12: -0.2110 REMARK 3 L13: 0.2433 L23: -0.2259 REMARK 3 S TENSOR REMARK 3 S11: -0.0213 S12: 0.0514 S13: -0.0106 REMARK 3 S21: 0.0699 S22: 0.0005 S23: 0.0099 REMARK 3 S31: -0.1020 S32: 0.1461 S33: 0.0026 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ENE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-APR-21. REMARK 100 THE DEPOSITION ID IS D_1300021793. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-X REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.541 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : RIGAKU HYPIX-6000HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO 1.171.40.73A REMARK 200 DATA SCALING SOFTWARE : CRYSALISPRO 1.171.40.73A REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25971 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.980 REMARK 200 RESOLUTION RANGE LOW (A) : 29.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.17.1_3660 REMARK 200 STARTING MODEL: 4YLU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4% V/V TACSIMATE PH 5.0, 0.1M SODIUM REMARK 280 CITRATE TRIBASIC PH 5.4, 12% V/V PEG 3,350, 8 MM CACL2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.47600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 465 MET B 305 REMARK 465 GLN B 306 REMARK 465 MET C 305 REMARK 465 GLN C 306 REMARK 465 MET D 305 REMARK 465 GLN D 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER C 1 OE2 GLU D 169 2.09 REMARK 500 OG1 THR B 105 OD1 ASN B 161 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH1 ARG A 79 OD2 ASP B 47 1655 1.53 REMARK 500 OG SER B 24 OD1 ASP D 33 1455 1.87 REMARK 500 OG SER C 50 ND2 ASN D 77 1455 2.06 REMARK 500 NH1 ARG A 79 CG ASP B 47 1655 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 79 CD - NE - CZ ANGL. DEV. = -9.4 DEGREES REMARK 500 ARG A 79 NE - CZ - NH2 ANGL. DEV. = 4.3 DEGREES REMARK 500 LYS A 224 CA - CB - CG ANGL. DEV. = 14.2 DEGREES REMARK 500 MET B 301 CG - SD - CE ANGL. DEV. = -16.8 DEGREES REMARK 500 ASP C 51 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP D 47 CB - CG - OD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -122.57 52.10 REMARK 500 HIS A 41 1.37 -67.77 REMARK 500 ASN A 53 75.96 -104.94 REMARK 500 GLN A 167 -32.38 -135.63 REMARK 500 ALA A 220 32.02 -146.36 REMARK 500 ASP B 33 -122.14 52.60 REMARK 500 HIS B 41 0.88 -69.60 REMARK 500 PRO B 45 30.65 -66.60 REMARK 500 ALA B 46 -16.49 73.50 REMARK 500 GLN B 167 -38.65 -136.81 REMARK 500 ALA B 220 31.10 -142.21 REMARK 500 ASP C 33 -122.35 52.48 REMARK 500 HIS C 41 0.25 -68.07 REMARK 500 GLN C 167 -33.19 -136.42 REMARK 500 ALA C 220 30.15 -143.38 REMARK 500 ASP D 33 -121.18 52.13 REMARK 500 HIS D 41 0.30 -68.76 REMARK 500 ALA D 220 29.48 -143.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J7R A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J7R B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J7R C 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J7R D 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7EN8 RELATED DB: PDB REMARK 900 7EN8 CONTAINS THE SARS-COV-2 3CLPRO COMPLEXED WITH THE SAME NON- REMARK 900 COVALENT INHIBITOR WU-04 REMARK 900 RELATED ID: 7END RELATED DB: PDB REMARK 900 7END CONTAINS THE SARS-COV 3CLPRO COMPLEXED WITH THE SAME NON- REMARK 900 COVALENT INHIBITOR WU-04 DBREF1 7ENE A 1 306 UNP A0A0A7E693_9BETC DBREF2 7ENE A A0A0A7E693 3248 3553 DBREF1 7ENE B 1 306 UNP A0A0A7E693_9BETC DBREF2 7ENE B A0A0A7E693 3248 3553 DBREF1 7ENE C 1 306 UNP A0A0A7E693_9BETC DBREF2 7ENE C A0A0A7E693 3248 3553 DBREF1 7ENE D 1 306 UNP A0A0A7E693_9BETC DBREF2 7ENE D A0A0A7E693 3248 3553 SEQRES 1 A 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 A 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 A 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 A 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 A 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 A 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 A 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 A 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 A 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 A 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 A 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 A 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 A 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 A 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 A 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 A 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 A 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 A 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 A 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 A 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 A 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 A 306 ILE MET GLY VAL VAL MET GLN SEQRES 1 B 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 B 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 B 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 B 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 B 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 B 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 B 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 B 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 B 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 B 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 B 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 B 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 B 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 B 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 B 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 B 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 B 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 B 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 B 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 B 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 B 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 B 306 ILE MET GLY VAL VAL MET GLN SEQRES 1 C 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 C 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 C 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 C 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 C 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 C 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 C 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 C 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 C 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 C 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 C 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 C 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 C 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 C 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 C 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 C 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 C 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 C 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 C 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 C 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 C 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 C 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 C 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 C 306 ILE MET GLY VAL VAL MET GLN SEQRES 1 D 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 D 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 D 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 D 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 D 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 D 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 D 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 D 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 D 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 D 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 D 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 D 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 D 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 D 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 D 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 D 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 D 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 D 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 D 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 D 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 D 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 D 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 D 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 D 306 ILE MET GLY VAL VAL MET GLN HET J7R A 401 34 HET J7R B 401 34 HET J7R C 401 34 HET J7R D 401 34 HETNAM J7R ~{N}-[(1~{S},2~{R})-2-[[4-BROMANYL-2-(METHYLCARBAMOYL)- HETNAM 2 J7R 6-NITRO-PHENYL]AMINO]CYCLOHEXYL]ISOQUINOLINE-4- HETNAM 3 J7R CARBOXAMIDE FORMUL 5 J7R 4(C24 H24 BR N5 O4) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 MET A 43 5 3 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 SER A 60 1 8 HELIX 5 AA5 MET A 184 PHE A 188 5 5 HELIX 6 AA6 CYS A 203 LEU A 216 1 14 HELIX 7 AA7 SER A 229 LEU A 238 1 10 HELIX 8 AA8 THR A 248 GLY A 259 1 12 HELIX 9 AA9 ALA A 261 TYR A 273 1 13 HELIX 10 AB1 THR A 292 MET A 301 1 10 HELIX 11 AB2 SER B 10 ALA B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 ASN B 53 SER B 60 1 8 HELIX 14 AB5 THR B 62 HIS B 64 5 3 HELIX 15 AB6 MET B 184 PHE B 188 5 5 HELIX 16 AB7 CYS B 203 ASN B 217 1 15 HELIX 17 AB8 SER B 229 LEU B 238 1 10 HELIX 18 AB9 THR B 248 GLY B 259 1 12 HELIX 19 AC1 ALA B 261 TYR B 273 1 13 HELIX 20 AC2 THR B 292 MET B 301 1 10 HELIX 21 AC3 SER C 10 ALA C 15 1 6 HELIX 22 AC4 HIS C 41 MET C 43 5 3 HELIX 23 AC5 ASN C 53 SER C 60 1 8 HELIX 24 AC6 THR C 62 HIS C 64 5 3 HELIX 25 AC7 MET C 184 PHE C 188 5 5 HELIX 26 AC8 CYS C 203 ASN C 217 1 15 HELIX 27 AC9 SER C 229 LEU C 238 1 10 HELIX 28 AD1 THR C 248 GLY C 259 1 12 HELIX 29 AD2 ALA C 261 TYR C 273 1 13 HELIX 30 AD3 THR C 292 MET C 301 1 10 HELIX 31 AD4 SER D 10 ALA D 15 1 6 HELIX 32 AD5 HIS D 41 CYS D 44 5 4 HELIX 33 AD6 PRO D 45 LEU D 49 5 5 HELIX 34 AD7 ASN D 53 SER D 60 1 8 HELIX 35 AD8 MET D 184 PHE D 188 5 5 HELIX 36 AD9 CYS D 203 ASN D 217 1 15 HELIX 37 AE1 SER D 229 GLN D 241 1 13 HELIX 38 AE2 THR D 248 GLY D 259 1 12 HELIX 39 AE3 ALA D 261 GLY D 275 1 15 HELIX 40 AE4 THR D 292 GLY D 302 1 11 SHEET 1 AA1 7 ALA A 76 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 LYS A 70 -1 N LYS A 70 O ALA A 76 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O TRP A 37 N LEU A 30 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N VAL A 81 O THR A 93 SHEET 1 AA2 5 ALA A 103 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 ALA A 171 1 O ILE A 160 N ALA A 103 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N THR A 154 O ASN A 161 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 ALA A 103 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 ALA A 171 1 O ILE A 160 N ALA A 103 SHEET 3 AA3 3 THR A 174 SER A 178 -1 O THR A 176 N GLN A 167 SHEET 1 AA4 7 ALA B 76 LEU B 78 0 SHEET 2 AA4 7 PHE B 66 LYS B 70 -1 N VAL B 68 O LEU B 78 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA4 7 MET B 25 LEU B 32 -1 O MET B 25 N CYS B 22 SHEET 5 AA4 7 THR B 35 PRO B 39 -1 O TRP B 37 N LEU B 30 SHEET 6 AA4 7 LEU B 89 VAL B 94 -1 O LEU B 90 N CYS B 38 SHEET 7 AA4 7 VAL B 80 GLN B 86 -1 N GLN B 86 O LEU B 89 SHEET 1 AA5 5 ALA B 103 THR B 105 0 SHEET 2 AA5 5 VAL B 159 ALA B 171 1 O ILE B 160 N ALA B 103 SHEET 3 AA5 5 VAL B 151 GLU B 156 -1 N THR B 154 O ASN B 161 SHEET 4 AA5 5 ALA B 114 TYR B 121 -1 N SER B 116 O TYR B 153 SHEET 5 AA5 5 ARG B 124 VAL B 132 -1 O PHE B 129 N VAL B 117 SHEET 1 AA6 3 ALA B 103 THR B 105 0 SHEET 2 AA6 3 VAL B 159 ALA B 171 1 O ILE B 160 N ALA B 103 SHEET 3 AA6 3 THR B 174 SER B 178 -1 O THR B 176 N GLN B 167 SHEET 1 AA7 6 PHE C 66 GLN C 69 0 SHEET 2 AA7 6 MET C 17 CYS C 22 -1 N GLN C 19 O GLN C 69 SHEET 3 AA7 6 MET C 25 LEU C 32 -1 O GLY C 29 N VAL C 18 SHEET 4 AA7 6 THR C 35 PRO C 39 -1 O TRP C 37 N LEU C 30 SHEET 5 AA7 6 LEU C 89 VAL C 94 -1 O LEU C 90 N CYS C 38 SHEET 6 AA7 6 VAL C 80 GLN C 86 -1 N VAL C 81 O THR C 93 SHEET 1 AA8 5 TYR C 104 THR C 105 0 SHEET 2 AA8 5 VAL C 159 ALA C 171 1 O PHE C 162 N THR C 105 SHEET 3 AA8 5 VAL C 151 GLU C 156 -1 N THR C 154 O ASN C 161 SHEET 4 AA8 5 ALA C 114 TYR C 121 -1 N SER C 116 O TYR C 153 SHEET 5 AA8 5 ARG C 124 VAL C 132 -1 O PHE C 129 N VAL C 117 SHEET 1 AA9 3 TYR C 104 THR C 105 0 SHEET 2 AA9 3 VAL C 159 ALA C 171 1 O PHE C 162 N THR C 105 SHEET 3 AA9 3 THR C 174 SER C 178 -1 O SER C 178 N MET C 165 SHEET 1 AB1 7 ALA D 76 LEU D 78 0 SHEET 2 AB1 7 PHE D 66 LYS D 70 -1 N LYS D 70 O ALA D 76 SHEET 3 AB1 7 MET D 17 CYS D 22 -1 N GLN D 19 O GLN D 69 SHEET 4 AB1 7 MET D 25 LEU D 32 -1 O MET D 25 N CYS D 22 SHEET 5 AB1 7 THR D 35 PRO D 39 -1 O TRP D 37 N LEU D 30 SHEET 6 AB1 7 LEU D 89 VAL D 94 -1 O LEU D 90 N CYS D 38 SHEET 7 AB1 7 VAL D 80 GLN D 86 -1 N VAL D 81 O THR D 93 SHEET 1 AB2 5 TYR D 104 THR D 105 0 SHEET 2 AB2 5 VAL D 159 ALA D 171 1 O PHE D 162 N THR D 105 SHEET 3 AB2 5 VAL D 151 GLU D 156 -1 N THR D 154 O ASN D 161 SHEET 4 AB2 5 ALA D 114 TYR D 121 -1 N SER D 116 O TYR D 153 SHEET 5 AB2 5 ARG D 124 VAL D 132 -1 O PHE D 129 N VAL D 117 SHEET 1 AB3 3 TYR D 104 THR D 105 0 SHEET 2 AB3 3 VAL D 159 ALA D 171 1 O PHE D 162 N THR D 105 SHEET 3 AB3 3 THR D 174 SER D 178 -1 O THR D 174 N ALA D 171 SITE 1 AC1 14 HIS A 41 PHE A 143 LEU A 144 CYS A 145 SITE 2 AC1 14 GLY A 146 CYS A 148 HIS A 166 GLN A 167 SITE 3 AC1 14 MET A 168 GLU A 169 ASP A 190 LYS A 191 SITE 4 AC1 14 VAL A 193 SER B 1 SITE 1 AC2 16 HIS A 64 HIS B 41 LEU B 49 PHE B 143 SITE 2 AC2 16 LEU B 144 CYS B 145 GLY B 146 CYS B 148 SITE 3 AC2 16 HIS B 166 GLN B 167 GLU B 169 ASP B 190 SITE 4 AC2 16 LYS B 191 GLN B 192 VAL B 193 GLN B 195 SITE 1 AC3 14 HIS C 41 LEU C 49 PHE C 143 LEU C 144 SITE 2 AC3 14 CYS C 145 GLY C 146 SER C 147 CYS C 148 SITE 3 AC3 14 HIS C 166 GLN C 167 GLU C 169 LYS C 191 SITE 4 AC3 14 GLN C 192 VAL C 193 SITE 1 AC4 15 HIS D 41 PHE D 143 LEU D 144 CYS D 145 SITE 2 AC4 15 GLY D 146 SER D 147 CYS D 148 HIS D 166 SITE 3 AC4 15 GLN D 167 MET D 168 GLU D 169 ASP D 190 SITE 4 AC4 15 LYS D 191 GLN D 192 VAL D 193 CRYST1 62.755 112.952 92.355 90.00 91.32 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015935 0.000000 0.000366 0.00000 SCALE2 0.000000 0.008853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010831 0.00000